Deceased breast cancer patients were older and were more likely to be post-menopausal, not to be diagnosed by screening, to have larger tumors, to have a higher number of involved lymph nodes, and to have luminal B-like, HER2+ and TNBC tumors. Here, ERBB2 is linked to breast carcinoma.